Skip to content
10-Q

Quarterly Report

INTERNATIONAL STEM CELL CORPORATION ISCO

0000950170-25-071338

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 12, 2025 8M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $5.11M
Current Liabilities Q1 2025 · Dec 31, 2024 $4.69M
Total Liabilities Q1 2025 · Mar 31, 2025 $5.41M
Total Liabilities Q1 2025 · Dec 31, 2024 $4.8M
Current Assets Q1 2025 · Mar 31, 2025 $3.84M
Current Assets Q1 2025 · Dec 31, 2024 $3.56M
Total Assets Q1 2025 · Mar 31, 2025 $5.62M
Total Assets Q1 2025 · Dec 31, 2024 $5.17M
Shares Diluted Q1 2025 · Mar 31, 2024 8M sh
Capex Q1 2025 · Mar 31, 2024 $8K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$193K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$4.26M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$4.19M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.03
Eps Basic Q1 2025 · Mar 31, 2024 −$0.03
Sga Expense Q1 2025 · Mar 31, 2024 $909K
Rd Expense Q1 2025 · Mar 31, 2024 $177K
Net Income Q1 2025 · Mar 31, 2024 −$214K
Operating Income Q1 2025 · Mar 31, 2024 −$178K
Cost Of Revenue Q1 2025 · Mar 31, 2024 $887K
Revenue Q1 2025 · Mar 31, 2024 $2.13M